Search Results - "FANCHINI, Laura"

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest by FALCONE, Alfredo, RICCI, Sergio, CORTESI, Enrico, PICONE, Vincenzo, VITELLO, Stefano, CHIARA, Silvana, GRANETTO, Cristina, PORCILE, Gianfranco, FIORETTO, Luisa, ORLANDINI, Cinzia, ANDREUCCETTI, Michele, MASI, Gianluca, BRUNETTI, Isa, PFANNER, Elisabetta, ALLEGRINI, Giacomo, BARBARA, Cecilia, CRINO, Lucio, BENEDETTI, Giovanni, EVANGELISTA, Walter, FANCHINI, Laura

“…The Gruppo Oncologico Nord Ovest (GONO) conducted a phase III study comparing fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI [irinotecan 165…”
Get full text

Response shift in health-related quality of life measures in the presence of formative indicators by Testa, Silvia, Di Cuonzo, Daniela, Ritorto, Giuliana, Fanchini, Laura, Bustreo, Sara, Racca, Patrizia, Rosato, Rosalba

“…Response shift (RS) has been defined as a change in the meaning of an individual's self-evaluation that needs to be accounted for when assessing longitudinal…”
Get full text

Supportive Care Needs and the Impact of Loss of Functioning and Symptom Burden on the Quality of Life in Patients with Advanced Colorectal Cancer by Miniotti, Marco, Bassino, Stefania, Fanchini, Laura, Ritorto, Giuliana, Leombruni, Paolo

“…Relationships between loss of functioning, symptom burden, supportive care needs, and quality of life (QoL) have been suggested in cancer populations. This…”
Get more information

Tailoring chemotherapy supply according to patients' preferences: a quantitative method in colorectal cancer care by Rosato, Rosalba, Di Cuonzo, Daniela, Ritorto, Giuliana, Fanchini, Laura, Bustreo, Sara, Racca, Patrizia, Pagano, Eva

“…Objectives: The aim of this study was to conduct a discrete choice experiment with patients affected by colorectal cancer to understand their preferences for…”
Get full text

CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies by Moretto, Roberto, Rossini, Daniele, Conca, Veronica, Lonardi, Sara, Rasola, Cosimo, Antoniotti, Carlotta, Santini, Daniele, Marmorino, Federica, Tomasello, Gianluca, Borelli, Beatrice, Caponnetto, Salvatore, Zucchelli, Gemma, Zaniboni, Alberto, Ambrosini, Margherita, Buonadonna, Angela, Fanchini, Laura, Cupini, Samanta, Masi, Gianluca, Falcone, Alfredo, Cremolini, Chiara

“…Background In mCRC, CEA is used to monitor response to systemic therapy together with imaging. After the end of induction, no major improvement in tumour…”
Get full text

Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial by Raimondi, Alessandra, Randon, Giovanni, Prisciandaro, Michele, Pagani, Filippo, Lonardi, Sara, Antoniotti, Carlotta, Bozzarelli, Silvia, Sartore‐Bianchi, Andrea, Tampellini, Marco, Fanchini, Laura, Murialdo, Roberto, Clavarezza, Matteo, Zaniboni, Alberto, Berenato, Rosa, Ratti, Margherita, Petrelli, Fausto, Antonuzzo, Lorenzo, Giordano, Monica, Rossi, Alessandro, Di Bartolomeo, Maria, Di Maio, Massimo, Pietrantonio, Filippo, Morano, Federica

“…Anti‐EGFRs plus doublet chemotherapy is considered the optimal upfront option for RAS/BRAF wild‐type left‐sided metastatic colorectal cancer (mCRC)…”
Get full text

Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO by Dell'Aquila, Emanuela, Rossini, Daniele, Galletti, Alessandro, Stellato, Marco, Boccaccino, Alessandra, Conca, Veronica, Germani, Marco Maria, Bergamo, Francesca, Daniel, Francesca, Spagnoletti, Andrea, Provenzano, Leonardo, Tomasello, Gianluca, Zaniboni, Alberto, Buonadonna, Angela, Fanchini, Laura, Cupini, Samanta, Carlomagno, Chiara, Caponnetto, Salvatore, Rapisardi, Stefania, Santini, Daniele

“…Obesity is associated with an increased risk of development and recurrence of colorectal cancer. The role of obesity in metastatic colorectal cancer patients…”
Get full text

Jaw Osteonecrosis associated with Aflibercept, Irinotecan and Fluorouracil: Attention to Oral District by Ponzetti, Agostino, Pinta, Francesco, Spadi, Rosella, Mecca, Caterina, Fanchini, Laura, Zanini, Marcello, Ciuffreda, Libero, Racca, Patrizia

“…Introduction The antiangiogenic monoclonal antibody aflibercept in association with fluorouracil and irinotecan improves the survival of patients with…”
Get full text

Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1 –Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer by Pinta, Francesco, Ponzetti, Agostino, Spadi, Rosella, Fanchini, Laura, Zanini, Marcello, Mecca, Caterina, Sonetto, Cristina, Ciuffreda, Libero, Racca, Patrizia

“…Micro-Abstract No effective preventive strategies for cetuximab-induced skin rash are available. In a homogeneous population of 41 consecutive patients with…”
Get full text

Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART) by Ricardi, Umberto, Racca, Patrizia, Franco, Pierfrancesco, Munoz, Fernando, Fanchini, Laura, Rondi, Nadia, Dongiovanni, Vincenzo, Gabriele, Pietro, Cassoni, Paola, Ciuffreda, Libero, Morino, Mario, Filippi, Andrea Riccardo, Aglietta, Massimo, Bertetto, Oscar

“…Neo-adjuvant chemo-radiotherapy (CT–RT) has been shown to decrease local recurrence rate in locally advanced rectal cancer. This multicenter phase II trial was…”
Get full text

Hemolytic uremic syndrome induced by infusion of oxaliplatin: A case report by Racca, Patrizia, Spadi, Rosella, Fora, Gianluca, Fanchini, Laura, Ritorto, Giuliana, Ferrari, Laura, Pinta, Francesco, Lista, Patrizia, Ciuffreda, Libero

“…Introduction Oxaliplatin is a third-generation platinum compound with proven antitumor activity in the treatment of colorectal cancer. The occurrence of…”
Get full text

Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation by Racca, Patrizia, Fanchini, Laura, Caliendo, Virginia, Ritorto, Giuliana, Evangelista, Walter, Volpatto, Roberta, Milanesi, Enrica, Ciorba, Angelica, Paris, Myriam, Facilissimo, Ivan, Macripò, Giuseppe, Clerico, Mario, Ciuffreda, Libero

“…Abstract Purpose The aim of this study was to investigate the efficacy of the combination of irinotecan/cetuximab and to plan related skin toxicity management…”
Get full text

Specific Detection of Cytokeratin 20-Positive Cells in Blood of Colorectal and Breast Cancer Patients by a High Sensitivity Real-Time Reverse Transcriptase-Polymerase Chain Reaction Method by Giribaldi, Giuliana, Procida, Simone, Ulliers, Daniela, Mannu, Franca, Volpatto, Roberta, Mandili, Giorgia, Fanchini, Laura, Bertetto, Oscar, Fronda, Gianruggero, Simula, Luigi, Rimini, Elena, Cherchi, Giovanni, Bonello, Lisa, Maule, Milena Maria, Turrini, Francesco

“…A real-time reverse transcriptase-polymerase chain reaction (RT-PCR) method for detection of cytokeratin 20-positive cells in blood characterized by two novel…”
Get full text